LI
TECX

Leap Investments’s Tectonic Therapeutic TECX Stock Holding History

Leap Investments’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,183
Closed -$201K – 614
2019
Q3 		$201K Buy
+1,183
New +$268K 0.1% 305

Other funds holding TECX

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Leap Investments's TECX Position: Q4 2019 in Review

Leap Investments sold out of Tectonic Therapeutic (TECX) in Q4 2019, closing a stake of 1,183 shares — an estimated $201K sold.

Leap Investments first reported a position in TECX in Q3 2019 and held it in 1 quarter. The position peaked at $201K in Q3 2019. 89 funds tracked by Wall St. Rank hold TECX as of Q4 2019.

  • Leap Investments reported no remaining Tectonic Therapeutic position as of Q4 2019 after selling out during the quarter.
  • Leap Investments sold 1,183 Tectonic Therapeutic shares in Q4 2019, an estimated $201K.
  • Leap Investments first reported a position in Tectonic Therapeutic in Q3 2019 and held it in 1 quarter.
  • Leap Investments's Tectonic Therapeutic position peaked at $201K in Q3 2019.
  • 89 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2019.

Based on Leap Investments's 13F filing for Q4 2019, filed 14 Feb 2020.